Jones Financial Companies
RNAM

Jones Financial Companies’s Avidity Biosciences RNAM Stock Holding History

Jones Financial Companies’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-284
Closed -$20.5K – 4889
2025
Q4 		$20.5K Buy
284
+85
+43% +$5.49K ﹤0.01% 2920
2025
Q3 		$8.55K Sell
199
-32
-14% -$1.29K ﹤0.01% 3143
2025
Q2 		$6.71K Sell
231
-103
-31% -$3.07K ﹤0.01% 3030
2025
Q1 		$10.6K Buy
+334
New +$10.4K ﹤0.01% 2675
2024
Q4 		– Sell
-55
Closed -$2.33K – 3488
2024
Q3 		$2.33K Buy
+55
New +$2.39K ﹤0.01% 2644

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Jones Financial Companies's RNAM Position: Q1 2026 in Review

Jones Financial Companies sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 284 shares — an estimated $20.5K sold.

Jones Financial Companies first reported a position in RNAM in Q3 2024 and held it in 5 quarters. The position peaked at $20.5K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Jones Financial Companies reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Jones Financial Companies sold 284 Avidity Biosciences shares in Q1 2026, an estimated $20.5K.
  • Jones Financial Companies first reported a position in Avidity Biosciences in Q3 2024 and held it in 5 quarters.
  • Jones Financial Companies's Avidity Biosciences position peaked at $20.5K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.